“CLEAR” technology can revolutionize protein imaging & facilitate detection of Cancer and Neurobiological Diseases A novel imaging platform called Cleavable Light-Erased Antibody Reporter (CLEAR) could help researchers visualize an unprecedented number of proteins within the same biological sample using just a single fluorescent marker. This could unveil new possibilities for high-resolution, multiplexed imaging across cells and tissues, with important implications for disease diagnosis and biological research. Proteins are the primary orchestrators of biological function and remain the principal targets for therapeutic intervention, as well as key markers for disease diagnosis. A comprehensive proteomic map of a tissue sample—capturing the identity and precise spatial organisation of every protein within its native context could help pathologists in diagnosing cancers or understanding complex neurological disorders. However, mapping a large number of proteins within their native spatial context has remained a major challenge. Read here: pib.gov.in/PressReleasePage.…